BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
+$415M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$247M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$186M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$179M |
| 5 |
Advanced Micro Devices
AMD
|
+$117M |
Top Sells
| 1 |
Apple
AAPL
|
+$547M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 3 |
Microsoft
MSFT
|
+$479M |
| 4 |
Amazon
AMZN
|
+$316M |
| 5 |
Diageo
DEO
|
+$288M |
Sector Composition
| 1 | Technology | 16.61% |
| 2 | Financials | 9.93% |
| 3 | Healthcare | 9.28% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Neogen
NEOG
$1.26B
| $6.11M | 0.01% |
437,069
+401,360
| +1,124% | +$5.61M |
|
752
Halozyme
HALO
$9B
| $6.09M | 0.01% |
153,911
+94,066
| +157% | +$3.72M |
|
753
Ironwood Pharmaceuticals
IRWD
$203M
| $6.08M | 0.01% |
586,772
+547,982
| +1,413% | +$5.68M |
|
754
United Microelectronic
UMC
$17B
| $6.07M | 0.01% |
1,089,042
-794,737
| -42% | -$4.43M |
|
755
Comerica
CMA
$8.92B
| $6.05M | 0.01% |
85,123
-26,012
| -23% | -$1.85M |
|
756
Cognex
CGNX
$7.52B
| $6.03M | 0.01% |
145,425
-66,752
| -31% | -$2.77M |
|
757
Agree Realty
ADC
$8.18B
| $6.01M | 0.01% |
89,003
+32,704
| +58% | +$2.21M |
|
758
Eastman Chemical
EMN
$7.8B
| $6.01M | 0.01% |
84,654
+48,401
| +134% | +$3.44M |
|
759
Fluor
FLR
$6.66B
| $6.01M | 0.01% |
241,590
-30,413
| -11% | -$757K |
|
760
DaVita
DVA
$9.55B
| $6.01M | 0.01% |
72,647
+36,117
| +99% | +$2.99M |
|
761
Vanguard Mortgage-Backed Securities ETF
VMBS
$14.9B
| $5.99M | 0.01% |
132,895
+48,868
| +58% | +$2.2M |
|
762
Fate Therapeutics
FATE
$116M
| $5.99M | 0.01% |
267,178
+160,430
| +150% | +$3.6M |
|
763
Evolent Health
EVH
$1.08B
| $5.96M | 0.01% |
165,943
+143,943
| +654% | +$5.17M |
|
|
OPA
764
DELISTED
Magnum Opus Acquisition Limited
OPA
| $5.96M | 0.01% |
+600,000
| New | +$5.96M |
|
765
PENN Entertainment
PENN
$2.93B
| $5.96M | 0.01% |
216,552
+17,750
| +9% | +$488K |
|
766
Canadian National Railway
CNI
$58.5B
| $5.95M | 0.01% |
+55,129
| New | +$5.95M |
|
|
TBSA
767
DELISTED
TB SA Acquisition Corp Class A Ordinary Share
TBSA
| $5.95M | 0.01% |
+800,000
| New | +$5.95M |
|
|
LDHA
768
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
| $5.94M | 0.01% |
+720,000
| New | +$5.94M |
|
769
Fidelity National Financial
FNF
$16.5B
| $5.94M | 0.01% |
170,516
-161,415
| -49% | -$5.62M |
|
770
Clarivate
CLVT
$2.94B
| $5.92M | 0.01% |
629,928
+531,153
| +538% | +$4.99M |
|
|
BGSX
771
DELISTED
Build Acquisition Corp.
BGSX
| $5.91M | 0.01% |
+800,000
| New | +$5.91M |
|
772
PPL Corp
PPL
$26.5B
| $5.91M | 0.01% |
233,293
-467,719
| -67% | -$11.9M |
|
|
SBII
773
DELISTED
Sandbridge X2 Corp.
SBII
| $5.91M | 0.01% |
+800,000
| New | +$5.91M |
|
774
Teck Resources
TECK
$20.4B
| $5.9M | 0.01% |
194,000
-69,194
| -26% | -$2.1M |
|
775
Vistra
VST
$69.3B
| $5.89M | 0.01% |
280,641
+165,710
| +144% | +$3.48M |
|